This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Edward A. Rittenhouse, MD; Hitoshi Mohri, MD, Dr Med Sci; Dennis D. Reichenbach, MD; K. Alvin Merendino, MD, PhD

AMA Arch Surg. 1972;105(5):752-755.

Abstract
An antithrombogenic aminoethylcellulose coating for Silastic valve prostheses was tested by implantation of coated, heparinized polyethylene cylinders into the thoracic inferior vena cava of dogs. The longest patency rate was achieved in the group that combined aminoethylcellulose (300 mg) with a mixture (2 ml) of Silastic fluid 360 and Silastic RTV 382 in a ratio of 1:2. One cylinder remained patent for 418 days, and the other three had not developed thrombus until 18, 53, and 120 days. In the other study groups, thrombus formation was consistently delayed for one week, but almost all cylinders eventually became occluded. These results are in marked contrast to the control groups where thrombosis had occurred during the first week in ten out of 14 cylinders examined. The aminoethylcellulose coating exerted an anticoagulant effect in vitro although the mechanism was not determined.

Author Affiliations
Seattle

From the departments of surgery (Drs. Rittenhouse, Mohri, and Merendino) and pathology (Dr. Reichenbach); and the First Surgical Service, University of Washington School of Medicine, Seattle. Dr. Mohri is serving as established investigator of the American Heart Association.

Footnotes
Accepted for publication May 26, 1972.

Reprint requests to Department of Surgery RF-25, University of Washington, Seattle 98195 (Dr. Mohri).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?